📖
Proteolysis inhibition by hibernating bear serum leads to increased protein content in human muscle cells
Stéphanie Chanon, Blandine Chazarin, Benoit Toubhans, Christine Durand, Isabelle Chery, Maud Robert, Aurélie Vieille-Marchiset, Jon M Swenson, Andreas Zedrosser, Alina M Evans, Sven Brunberg, Jon M Arnemo, Guillemette Gauquelin-Koch, Kenneth B Storey, Chantal Simon, Stéphane Blanc, Fabrice Bertile, Etienne Lefai

Proteolysis inhibition by hibernating bear serum leads to increased protein content in human muscle cells

Science & Mathematics Published 2018 Verification Pending

Overview & Synopsis

Muscle atrophy is one of the main characteristics of human ageing and physical inactivity, with resulting adverse health outcomes. To date, there are still no efficient therapeutic strategies for its prevention and/or treatment. However, during hibernation, bears exhibit a unique ability for preserving muscle in conditions where muscle atrophy would be expected in humans. Therefore, our objective was to determine whether there are components of bear serum which can control protein balance in human muscles. In this study, we exposed cultured human differentiated muscle cells to bear serum collected during winter and summer periods, and measured the impact on cell protein content and turnover. In addition, we explored the signalling pathways that control rates of protein synthesis and degradation. We show that the protein turnover of human myotubes is reduced when incubated with winter bear serum, with a dramatic inhibition of proteolysis involving both proteasomal and lysosomal systems, and resulting in an increase in muscle cell protein content. By modulating intracellular signalling pathways and inducing a protein sparing phenotype in human muscle cells, winter bear serum therefore holds potential for developing new tools to fight human muscle atrophy and related metabolic disorders. Muscle disuse atrophy is common in humans during immobilization, bedrest, spaceflight, denervation, cancer, and ageing, and therefore represents a major health issue 1–3 , and is also observed in a number of non-human models used for atrophy studies 4. Basic knowledge regarding the underlying mechanisms is continuously growing , and an intricate network of signalling pathways appears to be involved in the regulation of muscle fibre size, including IGF1-AKT-FOXO, inflammatory cytokines, NFκB signaling, myostatin, and glucocorticoids 5. However, there is still no fully effective therapy or prevention for disuse atrophy.

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Proteolysis inhibition by hibernating bear serum leads to increased protein content in human muscle cells
Author / Organization Stéphanie Chanon, Blandine Chazarin, Benoit Toubhans, Christine Durand, Isabelle Chery, Maud Robert, Aurélie Vieille-Marchiset, Jon M Swenson, Andreas Zedrosser, Alina M Evans, Sven Brunberg, Jon M Arnemo, Guillemette Gauquelin-Koch, Kenneth B Storey, Chantal Simon, Stéphane Blanc, Fabrice Bertile, Etienne Lefai
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2018
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-137103
Original Source Link Visit Source Page on hal.science »